Compound Detail
CHEMBL42
CLOZAPINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL42 |
| Name | CLOZAPINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QZUDBNBUXVUHMW-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
103
Targets
861
Activities
4
Assay Types
30
PK Parameters
20
Publications
20
Known Names
9
Indications
2
Mechanisms
Molecular Properties
326.8
MW (Da)
3.72
ALogP
4
HBA
1
HBD
30.9
PSA (Ų)
0.80
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1989 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 2a (5-HT2a) receptor antagonist | ANTAGONIST | 5-hydroxytryptamine receptor 2A | ✓ | ✓ |
| Dopamine D2 receptor antagonist | ANTAGONIST | D(2) dopamine receptor | ✓ | ✓ |
Indications
Psychotic Disorders Psychotic Disorders Schizophrenia Anxiety Bipolar Disorder Dementia Depressive Disorder Developmental Disabilities Intellectual Disability
ATC Classification
N05AH02
clozapine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Drug Warnings
Black Box Warning
hematological toxicity
Black Box Warning
cardiotoxicity
Black Box Warning
vascular toxicity
Black Box Warning
neurotoxicity
Black Box Warning
infectious disease
Activity Summary
Ki 634 meas. best 9.24
IC50 204 meas. best 8.52
Kd 16 meas. best 9.16
EC50 7 meas. best 9.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H1 receptor CHEMBL231 | EC50 | 9.4 | 9.4 | 0.4 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 9.24 | 8.675 | 0.6 | 10 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Kd | 9.16 | 8.89 | 0.7 | 2 |
| Unchecked CHEMBL612545 | Kd | 9.16 | 9.16 | 0.7 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 9.01 | 8.3833 | 1.0 | 6 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 8.94 | 8.16 | 1.1 | 3 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 8.92 | 8.0605 | 1.2 | 41 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 8.85 | 8.0133 | 1.4 | 18 |
| Unchecked CHEMBL612545 | Ki | 8.85 | 7.31 | 1.4 | 15 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 8.8 | 8.0062 | 1.6 | 29 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 8.74 | 8.15 | 1.8 | 10 |
| Muscarinic acetylcholine receptor M1 CHEMBL276 | Ki | 8.68 | 7.7367 | 2.1 | 3 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 8.54 | 7.91 | 2.9 | 26 |
| Histamine H1 receptor CHEMBL4701 | Ki | 8.54 | 8.23 | 2.9 | 3 |
| 5-hydroxytryptamine receptor 2A CHEMBL3446 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Histamine H1 receptor CHEMBL231 | Kd | 8.51 | 8.51 | 3.1 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 8.5 | 8.26 | 3.2 | 3 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 8.45 | 7.8775 | 3.6 | 4 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Ki | 8.43 | 7.8375 | 3.7 | 4 |
| Histamine H1 receptor CHEMBL3943 | Ki | 8.42 | 8.138 | 3.8 | 5 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 8.4 | 7.5717 | 4.0 | 12 |
| Alpha adrenergic receptor 1A and 1B CHEMBL2111476 | Ki | 8.4 | 8.4 | 4.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 8.4 | 8.1044 | 4.0 | 16 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 8.38 | 8.15 | 4.2 | 2 |
| Histamine H1 receptor CHEMBL231 | IC50 | 8.31 | 8.31 | 4.9 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2095200 | Ki | 8.3 | 8.11 | 5.0 | 2 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 8.26 | 7.6026 | 5.5 | 31 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 8.22 | 8.11 | 6.0 | 2 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 8.2 | 7.7 | 6.3 | 3 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.2 | 6.8747 | 6.4 | 15 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | Ki | 8.2 | 7.7667 | 6.3 | 3 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 8.19 | 8.19 | 6.5 | 1 |
| Homo sapiens CHEMBL372 | EC50 | 8.19 | 8.19 | 6.4 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.15 | 7.0024 | 7.1 | 80 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 8.12 | 7.044 | 7.5 | 15 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | IC50 | 8.11 | 7.585 | 7.8 | 10 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | IC50 | 8.11 | 7.76 | 7.8 | 6 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 8.1 | 8.1 | 7.9 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL324 | Ki | 8.1 | 7.7483 | 8.0 | 6 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 8.05 | 6.556 | 9.0 | 10 |
| D(4) dopamine receptor CHEMBL3361 | Ki | 8.05 | 7.6967 | 9.0 | 3 |
| Histamine H1 receptor CHEMBL4701 | IC50 | 8.05 | 7.7767 | 9.0 | 3 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 8.03 | 8.02 | 9.4 | 3 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 8.02 | 7.51 | 9.5 | 2 |
| D(4) dopamine receptor CHEMBL219 | Ki | 8.0 | 7.5778 | 10.0 | 55 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 8.0 | 7.8133 | 10.0 | 3 |
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 8.0 | 8.0 | 10.0 | 1 |
| Hypothalamus CHEMBL613575 | EC50 | 8.0 | 8.0 | 10.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.96 | 7.48 | 11.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1761.94 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 14.49 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.76 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 15.14 | mL.min-1.g-1 | Homo sapiens |
| CL | 150.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 0.000147 | mL.min-1.g-1 | Homo sapiens |
| CL | 1.2e-05 | mL.min-1.g-1 | Homo sapiens |
| CL | 0.44 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 0.07 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 2006.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 98.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.159 | uL/min | Homo sapiens |
| CL | 17.4 | mL.min-1.g-1 | Homo sapiens |
| CL | 10.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 82.4 | mL.min-1.kg-1 | Mus musculus |
| CL | 6.8 | mL.min-1.g-1 | Mus musculus |
| CL | 5.8 | mL.min-1.g-1 | Homo sapiens |
| CL | 20.4 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 35.9 | mL.min-1.g-1 | Mus musculus |
| CL | 55.1 | mL.min-1.kg-1 | Mus musculus |
| CL | 142.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 6.0 | nM | Rattus norvegicus |
| Cmax | 3490.0 | nM | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 199 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 62 |
| - | 10.6019/CHEMBL4295262 | Unchecked | 36 |
| 2571727 | 10.1021/jm00130a003 | Mus musculus | 27 |
| 23297297 | 10.1124/dmd.112.050484 | Cytochrome P450 3A4 | 25 |
| 17360666 | 10.1073/pnas.0611417104 | Mus musculus | 22 |
| 23297297 | 10.1124/dmd.112.050484 | Liver microsome | 19 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 23297297 | 10.1124/dmd.112.050484 | Cytochrome P450 2D6 | 16 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 11392544 | 10.1016/s0960-894x(01)00200-1 | Mus musculus | 14 |
| 2571727 | 10.1021/jm00130a003 | Rattus norvegicus | 11 |
| 18024584 | 10.1073/pnas.0709695104 | H4 | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 2891853 | 10.1021/jm00396a016 | Mus musculus | 10 |
| 8831770 | 10.1021/jm960268u | Rattus norvegicus | 10 |
| 15771414 | 10.1021/jm049629t | Rattus norvegicus | 10 |
| 34721 | 10.1021/jm00190a009 | Mus musculus | 10 |
| 16854056 | 10.1021/jm051008s | Histamine H4 receptor | 9 |
Data from ChEMBL 36 via Core Engine